MR

Marc Rosenberg

Healthcare Innovator | Investor

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Corporate Development
Strategic Planning
Business Strategy
Fundraising
Marketing
Clinical Research
Research
Treatment
Community Outreach
Statistics
Psychology
Neuroscience
Entrepreneurship
Leadership

Education

Lists including Marc

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

NV
Northpond Ventures

2021 - 2024

  • Senior Associate

    2021 - 2024

    $2.2B Life Science VC - Focused on Healthcare Technology/Health Services, Life Science Tools and Diagnostics Board Affiliations Included: DNAnexus Eleanor Health Hawthorne Effect OPT Industries Outcomes4Me Torus Biosystems Ultivue

TL
The Locus Initiative

2017 - 2023

  • Co-Founder and Strategic Advisor

    2017 - 2023

EH
Elements Health Ventures

2019 - 2021

  • Investor

    2019 - 2021

    Digital Health and Healthcare Tech-enabled Services Merchant Banking Arm of MTS Health Partners

MH
MTS Health Partners, L.P.

2019 - 2021

  • Investment Banking Analyst

    2019 - 2021

BT
BioAlert Technologies

2018 - 2020

  • Founder and CEO

    2018 - 2020

    Founded in 2018 and based in Philadelphia, BioAlert Technologies was a development stage medical device company dedicated to the design and development of continuous infection monitoring (CIM) systems for diabetic foot ulcer patients.